Trial Profile
Efficacy of two rurioctocog alfa prophylactic regimens following on-demand treatment in patients aged ≥14 years with severe haemophilia A
Status:
Not stated
Phase of Trial:
Phase IV
Latest Information Update: 09 Aug 2011
Price :
$35
*
At a glance
- Drugs Octocog alfa (Primary)
- Indications Haemophilia A
- Focus Therapeutic Use
- Acronyms RAHF-PFM
- 09 Aug 2011 New trial record
- 28 Jul 2011 Results presented at the 23rd Congress of the International Society on Thrombosis and Haemostasis.